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The protease separase plays a key role in sister chromatid disjunction and cen-
triole disengagement. To maintain genomic stability, separase activity is
strictly regulated by binding of an inhibitory protein, securin. Despite its cen-
tral role in cell division, the separase and securin complex is poorly understood
at the structural level. This is partly owing to the difficulty of generating a
sufficient quantity of homogeneous, stable protein. Here, we report the
production of Caenorhabditis elegans separase–securin complex, and its charac-
terization using biochemical methods and by negative staining electron
microscopy. Single particle analysis generated a density map at a resolution
of 21–24 A˚ that reveals a close, globular structure of complex connectivity
harbouring two lobes. One lobe matches closely a homology model of the
N-terminal HEAT repeat domain of separase, whereas the second lobe readily
accommodates homology models of the separase C-terminal death and
caspase-like domains. The globular structure of theC. elegans separase–securin
complex contrasts with the more elongated structure previously described for
theHomo sapiens complex, which could represent a different functional state of
the complex, suggesting a mechanism for the regulation of separase activity
through conformational change.1. Introduction
The stages of the eukaryotic cell cycle are defined on the basis of chromosomal
events and are referred to as G1, S, G2 and M phase. A cell in G1 phase commits
to divide in the presence of favourable growth conditions, or growth signals, and
enters S phase, the period when DNA synthesis takes place. During the synthesis
process, connections between the newly replicated DNA molecules, called sister
chromatids, are established [1–3], thus allowing the dividing cell to unambigu-
ously identify chromatids as sisters. Once the chromosomes have been
successfully duplicated the cell enters G2 phase. During mitosis, the dividing
cell faces the crucial task of accurately segregating complete copies of its genome
into a pair of daughter nuclei. The highly conserved cohesin complex holds the
sister chromatid together and contains four core subunits: the kleisin family
protein Scc1, two subunits of the structural maintenance of chromosomes Smc1
and Smc3, and the accessory subunit Scc3 [4]. Together, the core subunits form
a ring-like structure that is thought to topologically encircle the DNA helices of
the two sister chromatids [5–7]. A protease named separase dissolves the cohesion
between the sister chromatids by cleaving Scc1 at the onset of anaphase [2,8–10].
Although separase is expressed throughout the cell cycle [11], it is inactive
during most stages of the cell cycle owing to complex formation with its inhibi-
tor securin [8,12,13]. This stable complex persists until shortly before the onset
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2of anaphase when securin degradation is initiated by the ana-
phase-promoting complex/cyclosome (APC/C) [11,12,14].
While securin inhibits separase, it also plays a positive role
in promoting its function. Experiments in budding yeast
and human cells have demonstrated that securin is needed
for full separase activity after itself has been degraded
[13,15–17], indicating that securin is a chaperone for separ-
ase. This is supported by results from Schizosaccharomyces
pombe and Drosophila melanogaster in which the absence of
securin is lethal as it leads to an apparent lack of separase
activity [14,18]. Several lines of evidence suggest that securin
stabilizes separase: the accumulation of overexpressed separ-
ase has been reported to require co-expression of securin [19];
separase levels are over fourfold reduced in securin2/2 cells
[17]; and the protein levels of budding yeast separase are
three times lower in G1, when securin cannot be detected
in the cell, than in other phases of the cell cycle [11]. The con-
tribution of securin to separase stability is harder to ascertain
in higher eukaryotes in which the levels of separase also fluc-
tuate due to protein instability following autocleavage [19].
Separases are large proteins with molecular weights ran-
ging from 140 to 240 kDa, with a few exceptions including
Drosophila homologues. They belong to clan CD of cysteine
peptidases, and are related to caspases and gingipain [20].
The catalytic activity of separases resides in their well-
conserved C-terminal half, a region predicted to contain a
domain common to caspases [21]. This domain harbours the
strictly conserved histidine and cysteine residues needed for
catalytic function [10,22]. In caspases and gingipain, the histi-
dine and cysteine residues are brought into juxtaposition by
association of the two hydrophobic beta sheets that bring the
two amino acids close enough to one another to form the cata-
lytic dyad [23,24]. In addition to the caspase-like domain,
the C-terminal region is also predicted to contain a Death
domain [21]. The N-terminal region of separase is thought to
consist of Armadillo (ARM) orHEATmotifs that forma-helical
repeats [25,26]. The C-terminal domain is separated from the
N-terminal half by an unstructured central stretch (a ‘hinge
region’). Pull-down studies reveal that the N- and C-terminal
halves of both human and budding yeast separase form a com-
plex [13,25]. Moreover, in yeast, the entire N-terminal region
seems to be necessary for catalytic activity of the C-terminal
caspase-like domain [13].
Securin proteins have extremely divergent primary
sequences and, consequently, they can be challenging to ident-
ify through bioinformatics approaches [14,18,27,28]. Human
securin is natively unfolded with only a small, transient helical
region [29,30]. The region of securin that binds and inhibits
separase has been identified in several systems, including
fission yeast [31], D. melanogaster [25] and budding yeast [13].
A number of biochemical studies have been carried out to
map the separase and securin interaction, which is stable
even under high-salt conditions [32]. Interaction studies
firmly establish that the C-terminal part of securin and the
N-terminal region of separase are important for complex for-
mation [11,13,25,26,30]. However, structural studies on the
separase–securin complex have been limited by the difficulty
of generating substantial quantities of stable sample. Indeed,
the only published study is a low-resolution electron micro-
scopic (EM) analysis of the human complex that showed a
flexible, elongated structure [26].
We set out to study the separase/securin complex from
Caenorhabditis elegans, in which the separase protein appearsto be smaller and more highly ordered than homologues
from other model organisms. Here we present the expression,
purification and biochemical characterization of this complex.
Negative stain EM and single particle reconstruction revealed
the overall shape of the complex at a resolution of approxi-
mately 24 A˚ corresponding to a globular two-lobed structure
that differs substantially from that of the equivalent complex
from humans. The C. elegans structure can be interpreted in
terms of homology models of the N-terminal HEAT repeat
domain and C-terminal death and caspase-like domains
of separase.2. Results
2.1. Bioinformatic analysis and domain structure
assignment of Caenorhabditis elegans separase
Secondary structure prediction was carried out on separase
from C. elegans, H. sapiens and S. cerevisiae using PsiPred [33].
The N-terminal region was predicted to be mostly a-helical
with varying helix lengths. Previous published analysis
suggests that this region of human separase is composed of
ARM or HEAT repeats [25,26]. Fold recognition predictions
carried out using HHpred [34] and Phyre2 [35] matched the
N-terminal regions of separase from H. sapiens, S. cerevisiae
and C. elegans to helical and super-helical structures such as
Tpr repeats, and, with less confidence, ARM or HEAT repeats.
These three types of repeat all give rise to right-handed sole-
noid structures: whereas ARM regions have three helices per
repeat, HEAT and Tpr regions have two helices per repeat
and are distinguished at a sequence level or by the usually
larger curvature of HEAT regions [36]. However, in the case
of C. elegans separase, sequences did not clearly fit a consensus
and were only partly modelled by either programme, indicat-
ing that the N-terminal part of separases contains a non-
canonical fold of ARM/HEAT repeats or a super-helical struc-
ture that is not part of either fold. This is likely to be due to
these repeats often being highly diverged, making the predic-
tion of the positions of HEAT or ARM domains challenging
[37]. The N-terminal region of C. elegans separase also contains
a predicted disordered region from residue 400 to 440, as well
as three beta-strands from residue 720 to 750 (figure 1a). The
analysis revealed a feature seemingly unique to the worm
homologue: whereas the C-terminus of most homologues lies
at the end of the caspase-like domain, theC. elegans homologue
has an additional 120 residues C-terminal to the caspase-like
domain. The core region of the C. elegans separase homologue,
comprising the a-helical repeat region and the caspase-
like region, is smaller than that of other separase proteins,
and so we investigated its suitability as a model system for
structural studies.
2.2. Co-expression of separase and securin stabilizes
the complex
Attempts to express separase, or parts of C. elegans separase,
in Escherichia coli did not yield any soluble protein that was
folded and stable. However, it has been suggested that securin
functions not only as an inhibitor of separase but also as
its chaperone [17,19], and co-expressing the inhibitor with
separase was therefore attempted. However, co-expression of
separase
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Figure 1. Securin increases the expression of full-length and N-terminal fragments of separase. (a) Predicted domain structure of separase proteins. (b) Expression of
His6-separase and co-expression with His6-securin in Sf9 insect cells. Samples were taken on days 1–3 from a culture of Sf9 cells infected with virus containing His6-
separase constructs only, or viruses containing both His6-separase and His6-securin constructs. Samples were analysed by Western blot, using a-His6 primary anti-
body, and by loading twice the amount of separase only samples versus separase and securin samples. Both separase and securin are indicated. Lane M indicates the
molecular weight marker. (c) Size exclusion chromatogram of full-length (FL) C. elegans separase when expressed and purified with securin. Three peaks are visible
which correspond to void (peak a), separase–securin complex ( peak b) and securin alone (peak c). Purification of separase alone leads to an accumulation of the
protein in the void. (d ) Fractions from SEC of separase co-expressed with securin were analysed by SDS–PAGE. Lane 1 is the input sample. Peak a consists of
separase protein (lanes 2–4). Peak b consists mostly of separase–securin complex (lanes 5–7). Un-complexed securin elutes as peak c (lanes 8–12). Lane
14 shows a molecular weight marker (M).
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3N-terminal separase constructs with full-length securin as well
as co-expression of N- and C-terminal separase constructs in
E. coli did not give rise to any change in expression pattern
or stability of the proteins.
We expressed different constructs of C. elegans separase in
Sf9 insect cells, corresponding to full-length and three
C-terminal truncations. In each case, expression yields were
increased by co-expression with securin as analysed by
SDS–PAGE, and we loaded twice the amount of separase-
only samples per lane versus separase and securin samplesto aid visual analysis (figure 1b). The increase in expres-
sion yields for the C. elegans homologues ranged from
approximately two times more (construct 1–1140) to around
eight times more (construct 1–579) separase expressed, con-
firming reported observations that securin is required for
accumulation of the protease [17,19].
We carried out large-scale purifications of separase alone
and in complex with securin, and used size exclusion chrom-
atography (SEC) to evaluate the suitability of the samples for
structural studies. SEC of full-length separase alone showed a
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Figure 2. Structural and biochemical analysis of C. elegans securin. (a) E. coli-
expressed C. elegans securin was analysed with CD spectroscopy. Spectra of
secondary structure CD standard curves are shown for comparison. (b) Separ-
ase accumulation is highest when co-expressed with full-length (FL) securin
and 77–244. Separase and securin fragments, as well as the full-length pro-
teins, were co-expressed in Sf9 cells. After 72 h of expression the cells were
harvested, lysed (samples ‘L’) and the insoluble fraction separated. The sol-
uble fraction (samples ‘S’) was incubated with Strep–Tactin resin to bind the
StrepII-tagged separase ( pull-down, samples ‘P’). Samples were analysed
with SDS–PAGE, and proteins visualized with Western blots to detect separ-
ase (top blot) and securin (bottom blot). Truncation mutants of securin, and
FL protein are shown schematically at the bottom of the panel, and shaded
by their propensity to form a robust complex with separase (black, most
robust; white, no detectable complex).
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4large peak corresponding to the void volume, indicating the
presence of soluble aggregates of separase (figure 1c, dotted
line, peak a). A proportion of the separase/securin complex
also eluted in the void volume, but two further peaks in
the chromatogram became more apparent (figure 1c, solid
line, peaks b and c). Peaks b and c correspond to separase/
securin complex and securin, respectively (figure 1d ).
2.3. Caenorhabditis elegans securin is a disordered
protein that interacts with separase through its
C-terminal region
Previously, it was shown that human securin is an intrinsi-
cally disordered protein [29,30]. We expressed and purified
His6-tagged securin from C. elegans, and analysed the puri-
fied protein using circular dichroism (CD) spectroscopy to
experimentally determine the degree of secondary structure
in the protein. A CD spectrum of the protein was recorded
from 190 to 260 nm at 258C (figure 2a) and subsequently ana-
lysed for quantitative estimation of the secondary structure
content. The results revealed that C. elegans securin contains
6% a-helices, 6–8% b-strands, 4–8% turns and 76–84%
random coils. The minimal number of secondary structure
elements in C. elegans securin, along with the published results
that H. sapiens securin is also an unfolded protein [29], suggest
that disorder is a conserved feature of securin proteins, at least
when overexpressed in the absence of separase.
Bioinformatic analysis unveiled a very uneven charge dis-
tribution in the C. elegans securin sequence: its N-terminus
(amino acid 1–76) contains predominantly positively charged
amino acids (Lys, Arg), whereas the remainder of the protein
(amino acid 77–244) contains a large number of negatively
charged amino acids. The C-terminal region (207–244) has a
cluster of predicted a-helices. To define a minimal separase-
binding fragment of securin, batch purification experiments
on StrepTactin resin were carried out using truncated securin
proteins co-expressedwith separase (aa 1–1140). Four different
fragments of securin were expressed (1–76, 77–206, 77–244
and 155–244), and their expression and interactions were eval-
uated using SDS–PAGE and Western blots (figure 2b;
electronic supplementary material, figure S1a). Only the full-
length securin and 77–244 fragment formed stable complexes
with separase. Securin fragments 1–76 and 77–206 did not
interact with separase, whereas expression of the 155–244
fragment could not be detected.
2.4. Purification of the full-length separase–
securin complex
Our original purification strategy used His6-tagged separase,
but we found that imidazole strongly destabilized the ther-
mal stability of the separase–securin complex (electronic
supplementary material, figure S1b), and so we focused on
optimization of protocols for purification of complex to hom-
ogeneity based on strep II-tagged separase (figure 3a;
electronic supplementary material, figure S1c). The size exclu-
sion elution profile of the separase–securin complex shows
one peak, which contains both separase and securin and indi-
cates complex formation (electronic supplementary material,
figure S1d; figure 3b). Multi-angle light scattering (MALS) in
conjunction with SEC was used for determining the sizedistribution and the accurate molecular mass of the complex
[38]. SEC–MALS measurements confirmed the complex as a
single species and gave an estimated molecular mass of
174 kDa (figure 3c), consistent with a 1 : 1 complex of separase
(molecular weight of 144.2 kDa) and securin (molecular weight
of 27 kDa).
2.5. Three-dimensional structure of the separase/securin
complex
Transmission electron microscopy in conjunction with single
particle analysis was carried out to gain structural insights
into complex formation between separase and securin.
Negative stained samples of full-length C. elegans separase–
securin complex gave rise to molecular images (figure 4a,
encircled) of consistent dimensions and with sufficient detail
97 kDa 
64 kDa 
StrepII–separase
MBP-securin
191 kDa 
1 2 3 4 5 6 7 8 9 10 11
1 2 3 4 5 6 7 8 9 10 11
12 13 14 15
M(a)
(b)
(c)
97 kDa 
191 kDa 
39 kDa 
x
StrepII–separase
securin
M
10 000
100 000
10 00 000
24 25 26 27 28 29
time (min)
m
o
la
r m
as
s (
g m
ol–
1 )
0
0.2
0.4
0.6
0.8
1.0
dR
I (
rel
ati
ve
 sc
ale
)
Figure 3. Purification of the separase–securin complex. (a) First purification
step: elution fractions from a Strep–Tactin resin analysed by SDS–PAGE.
(b) SDS–PAGE analysis of fractions corresponding to the main peak (x) of
the SEC shown in electronic supplementary material, figure S1d. (c) SEC–
MALS analysis of the separase/securin complex. Normalized dRI signal
(blue line, right y-axis) was plotted against elution time and shows one
peak confirming a monodisperse solution. The molar mass distribution (red
line, left y-axis) confirms that the elution peak consists of one species
with the molecular weight of 174 kDa.
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5for three-dimensional analysis. Reference-free class averages
typically appear divided into two lobes, differing in size and
shape, separated by a central region of stain accumulation
(figure 4b). An initial three-dimensional map of the C. elegans
separase–securin complex was generated in C1 symmetry
(i.e. no internal symmetry) from class averages with projection
angles assigned by angular reconstitution in Imagic. The struc-
turewas then subjected to 10 cycles of refinement, consisting of
multireference alignment, three-dimensional reconstruction
and reprojection (figure 4c; electronic supplementary material,
figure S2). The final, refined three-dimensional map displayed
with a threshold consistent with a mass of 174 kDa, as deter-
mined by SEC–MALS (figure 3c), has a complex, globular
shape with sufficient detail to show two structural lobes and
their connectivity (figure 5a). The resolution of the refined
map was calculated as approximately 24 A˚ (electronic sup-
plementary material, figure S3). A notable feature of the map
is a central cavity with dimensions of approximately 60 A˚ 
40 A˚ that separates the two structural lobes. The lobes are con-
nected by a thin linker.We next set out to determine a plausible arrangement of
separase and securin in the complex. The larger lobe in the
top half of the map (figure 5b, middle image) represents
approximately 54% of the total mass of the complex, or
93.5 kDa, whereas the smaller lobe has an estimated molecu-
lar mass of 80.5 kDa. We generated a model of the helical
repeat region of separase using i-Tasser [39]. This model
has a ‘lock-washer’ shape made up of HEAT repeats that
matches quite well the smaller lobe of the map (electronic
supplementary material, figure S4a). The agreement between
this model and the map density was further improved using
the molecular dynamics flexible fitting (MDFF) procedure
while preserving the overall conformation of the model (elec-
tronic supplementary material, figure S4b) [40]. We had
previously generated a molecular model of the caspase-like
domain of C. elegans separase, which is globular in shape
and extends over 50 A˚ in its longest dimension, and only
fits into one subregion of the map, in the larger lobe [21].
We therefore annotated the two lobes as representing the
N- and C-terminal regions of separase. Next, we fitted the
death-like domain into a subregion of the C-terminal lobe
adjacent to the caspase-like domain. We were unable to gen-
erate structural models for securin and the C-terminal region
of separase (aa 1140–1262), and these sequences were not
fitted into the map, which has regions of unmodelled density,
particularly in the larger lobe. The caspase-like domain was
modelled in complex with a substrate peptide based on C. ele-
gans Scc1 (green, figure 5b) [21]. Although the active site of
separase is exposed on the outer surface of the protein,
access for large substrates is occluded by two neighbouring
domains in the quaternary structure: a region of the N-term-
inal helical repeats (approx. aa 250–450), and an unassigned
region of density that protrudes from the C-terminal lobe
towards the N-terminal repeats (‘crooked tooth’).3. Discussion
In this study, we report the production of recombinant
separase–securin complex from C. elegans as well as its
three-dimensional structure determined in negative stain
from electron microscopic images.
We were not able to express separase alone or any trunca-
tion versions thereof in large scale using bacterial or insect
cell expression systems. However, large amounts of soluble
separase–securin complex were obtained in insect cell culture.
A two-step purification protocol resulted in pure, monodis-
perse complex. This supports previous findings that the
protease needs to be expressed with its inhibitor to accumulate
and that securin functions as a chaperone for separase
[11,13,14,17,19]. Further analysis of this complex using SEC–
MALS revealed that the two components were present in
equal stoichiometry.
3.1. A closed conformation of the separase–securin
complex is consistent with its biochemical
properties
Our analysis of the C. elegans complex is consistent with pre-
vious studies that showed, in homologues from diverse
organisms, that the N-terminal region of separase and the
C-terminal part of securin are important for complex
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90°
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100 Å
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Figure 4. Electron microscopic analysis of negatively stained separase–securin complex. (a) A characteristic micrograph of freshly purified full-length C. elegans
separase–securin complex is shown. The complex was bound to glow-discharged, carbon-coated quantifoil grids and stained for EM using 2% w/v uranyl acetate.
Examples of molecular views are circled. (b) Reference-free two-dimensional class averages of the separase–securin complex represent characteristic molecular views
of the complex with a high signal-to-noise ratio. Reference-free class averages of the C. elegans separase–securin complex were generated by REFINE2D from EMAN.
(c) Refinement progress of the separase–securin model from angular reconstitution. The model is shown in three orthogonal views after the first (sea-green) and
fifth (blue) round of refinement, as well as the refined model (grey) after a total of 10 refinement rounds. The models were contoured to give a mass of 174 kDa.
rsob.royalsocietypublishing.org
Open
Biol.6:160032
6formation [13,16,25,26]. It is also thought that the middle part
of securin contributes significantly to the interaction, that
securin also interacts with the C-terminal region of separase,
and that the N- and C-terminal regions of separase interact
[13,25,41]. These data suggest that the securin–separase com-
plex must adopt a compact structure, in which interactions
can occur between separase domains that are separated in pri-
mary sequence, with securin acting as a bridge between them.Electron microscopy studies at 21–24 A˚ resolution revealed an
overall compact architecture of the C. elegans separase–securin
complex. Homology models of individual separase domains
could be docked into the three-dimensional structure in an
arrangement that closely matches the protein density and is
compatible with these proposed domain interactions.
The structure described here is the second three-
dimensional structure of a separase–securin complex reported,
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Figure 5. Structural model of the C. elegans separase–securin complex.
(a) The refined C. elegans separase–securin structure shown in different
views. This model shows intricate connectivity and a good amount of
detail. The two structural domains are clearly distinguishable, as well as
the central cavity. The model was contoured to give a mass of 174 kDa.
(b) Mesh representation of the separase–securin complex and modelled
separase domains, colour-coded; helical repeats (blue), death-like domain
( pink), caspase-like domain (red) and Scc1 peptide substrate (green).
(c) Schematic models of the separase/securin complex from C. elegans
(this study) and H. sapiens. A closed, inactive form of the complex is consist-
ent with its biochemical properties, such as inability to bind Scc1 protein
substrate. We hypothesize that the open form of the human complex rep-
resents a partially active state of the complex, in which autocleavage
occurs and Scc1 binding might be possible.
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7and the first from an invertebrate source. The C. elegans separ-
ase–securin complex is of globular shape, with an intricate
connectivity and a large central cavity that separates two
domains. Strikingly, the presence of two domains is the only
feature in common between the C. elegans model and the pre-
viously published H. sapiens model [26]. Although both
density maps are nominally the same resolution, there are
no obvious domain similarities in the two structural maps.
The human complex shows an elongated shape, whereas the
C. elegans model has a globular shape. Furthermore, there are
clearly more features present in the C. elegans model, such as
a number of protrusions similar in shape to helical repeats.
This is particularly the case in the smaller lobe, which formsa lock washer motif that is closely compatible with the stacked
HEAT repeat homology model predicted for residues 1–720 of
separase. It is difficult to identify such features in theH. sapiens
structure with the overall surface of the model being rather
smooth and featureless. The models also have a very different
overall appearance; the C. elegans structure is relatively globu-
lar with a large central cavity, whereas the H. sapiens structure
is larger, elongated and without a central cavity.
Despite the low sequence identity in separase and securin
homologues, it was unexpected to see such lack of structural
conservation as both proteins belong to the same family of
proteins and exert the same function. Cohesin and its com-
ponent Scc1 are well conserved, and separase and securin
are essential genes. Therefore, it could be expected that the
evolutionary pressure on the complex to preserve its function
was too high to give rise to this structural diversity. It might
be the case that the two structures reflect genuine differences
in the human and C. elegans complexes. However, it is tempt-
ing to speculate that the two structures might indicate two
very different conformations for separase that could be
associated with different functional states. Flexibility in the
complex would not be surprising, because securin is an
intrinsically disordered protein, and separase is a multi-
domain protein composed mainly of helical repeats, which
have well-documented flexibility [37,42–45].
Support for the existence of two biochemically distinct
forms of the separase–securin complex is found in an elegant
series of experiments using inhibitory peptides that mimic
Scc1 substrate and covalently bind to the active site cysteine
of separase [13,19]. These studies, using human and yeast
proteins, showed that securin inhibits separase by blocking
access of substrates to the active site, because pre-incubation
of separase with securin prevented binding of peptide inhibi-
tor. However, when inhibitor was bound to separase first,
this did not markedly reduce the binding of securin to separ-
ase, indicating that securin can bind to separase by contacting
residues outside the active site of separase, such as the
N-terminal region. Based on these studies, it was proposed
that securin does not directly compete with substrate for
active site binding, but instead alters the conformation of
separase, so that the active site is inaccessible to substrate.
The ‘closed’ shape of the C. elegans complex bears a striking
resemblance to the models proposed for securin inhibition
of separase based on these biochemical data, in contrast to
the ‘open’ shape of the human complex (figure 5c). We tenta-
tively suggest the human complex might represent a partly
active form of the complex that appeared during the multi-
step purification. Indeed, the complex purified by Viadiu
et al. [26] was partly active as evidenced by separase autoclea-
vage. We hypothesize that securin holds the two lobes of
separase together and that proteolysis of securin opens up
the protein, allowing access to the active site. However, in
this model, it is unclear how the interaction between the
N-terminal repeats and the caspase-like domain enhances
separase activity. An alternative model is that securin
blocks the interaction between the two lobes and that, upon
securin proteolysis, closure of the two lobes enables the N-
terminal repeats to activate the caspase-like domain through
an allosteric mechanism.
Further structural studies will be required to address
many of the aspects of separase regulation that remain unre-
solved. For example, we still do not know why securin is
required to stabilize separase, how securin inhibits separase
rsob.royalsocietypublishing.or
8or the precise details of protease activation. Addressing many
of these questions will require an improvement in the resol-
ution of the separase–securin structure by using cryo-EM
or by X-ray crystallography, and through studies on separase
in an active state. The difficulty in producing recombinant
complex that is stable and amenable to structural studies
has been a limiting factor in structural studies on this com-
plex, and so the recombinant expression and purification of
the C. elegans separase–securin complex will greatly facilitate
future studies.g
Open
Biol.6:1600324. Material and methods
4.1. Expression plasmid construction
Caenorhabditis elegans separase was cloned into pET30-TEV for
bacterial expression. For expression in Sf9 cells, all constructs
were cloned into either pFBDM-His [46] or pFBDM-strepII,
which was generated by inserting a double strepII tag contain-
ing a PreScission cleavage site into the PH promoter of pFBDM
using BamHI and BssHII endonucleases. For co-expression of
His6-tagged separase and MBP-tagged securin in insect cells,
separase was placed under the p10 promoter of pFBDM-His
using XmaI and KpnI, whereas MBP-securin was amplified
from pET30-MBP and inserted into the vector with BamHI
and NotI endonucleases.
4.2. Protein expression and purification
His6-tagged C. elegans separase was expressed in E. coli BL21
CodonPlus RIL (Stratagene) in LB media at 378C overnight
after induction with 0.3 mM IPTG. Cell pellets were stored at
2808C until required. Thawed cell pellet was resuspended in
Tris buffer (50 mMTris, 0.3MNaCl, 1 mMMgCl2, 2 mM2-mer-
captoethanol, pH7.5) containing 1EDTA-freeprotease inhibitor
cocktail tablet (Roche). Cells were lysed by sonication. Cleared
lysates were applied to a 5 ml Ni–NTA superflow column
(Qiagen), washedwith Tris buffer containing 20 mM imidazole,
and the bound proteins were eluted with a 0.02–0.5 M imida-
zole gradient. Pooled fractions containing His6-securin were
cleaved using His6–TEV protease during overnight dialysis
into TEV buffer (50 mM Tris, 0.1 M NaCl, 2.5 mM MgCl2,
2 mM 2-mercaptoethanol, pH 7.5). The cleaved protein was
separated from His6–TEV using a Ni–NTA column, then
further purified using SEC in Tris buffer.
Baculovirus production was carried out essentially as
described in the Invitrogen guide to baculovirus expression
vector systems [47]. Small-scale infections used 10 ml of Sf9
cells at a density of 1.2–1.8  106 cells ml21 were infected
with P2 virus using multiplicity of infection of 2. The infected
cells were cultured in Erlenmeyer flasks, using 10% of the
nominal volume, at 278C and 140 r.p.m., for 72 h. The cells
were harvested by centrifugation, and the pellet stored at
2808C until needed or further processed immediately. The
protocol was modified for large-scale infections: after infect-
ing 400 ml of cell culture with P3 virus, the cells were
cultured in roller bottles using 20% of the nominal volume.
Pelleted cells from small-scale cultures were sonicated on
ice in PBS buffer containing 0.05% v/v nonidet and EDTA-
free protease inhibitor cocktail set III (Calbiochem). Clarified
cell lysate was mixed with approximately 25 ml of the appro-
priate affinity resin slurry (Ni superflow resin, Generon;amylose resin, NEB; StrepTactin superflow plus, Qiagen),
incubated for 1 h at 48C, and the resin was pelleted by centrifu-
gation. The resin was washed four times in PBS buffer
(containing 10 mM imidazole when working with His6-
tagged proteins), and samples were analysed by SDS–PAGE
and Western blot.
Pelleted cells from large-scale cultures were resuspended
in either Tris buffer (50 mM Tris, 0.2–0.5 M NaCl, 2 mM
b-mercaptoethanol, pH 7.0) or phosphate buffer (50 mM Tris,
0.5M NaCl, 2 mM b-mercaptoethanol, pH 7.0), supplemented
with 0.05% v/v nonidet and protease inhibitors. Cells were
lysed using a manual homogenizer, clarified and filtered.
His6-tagged proteins and complexes were loaded onto a 5 ml
Ni–NTA superflow column (Qiagen), washed with Tris or
phosphate buffer containing 20 mM imidazole, and eluted
with a 0.02–0.5 M imidazole gradient. StrepII-tagged proteins
were loaded onto a 5 ml StrepTactin superflow plus column
in phosphate buffer, and bound proteins were eluted with a
phosphate buffer containing 2.5 mM D-desthiobiotin. MBP-
securin/separase complexes were applied to amylose resin,
washed with Tris or phosphate buffer and cleaved off the
resin using TEV protease. The protein pool was concentrated
and loaded onto a Superdex 200 16/60 SEC column or an
analytical Superose 6 10/300 column (GE Healthcare)
pre-equilibrated in Tris buffer, or phosphate buffer. Eluted
fractions were analysed by SDS–PAGE and Western blots.
4.3. Circular dichroism spectroscopy
CDmeasurements of full-length His6-tagged C. elegans securin
were carried out using a 0.75 mg ml21 protein sample in a
buffer comprising 35 mM Tris, 0.1 M NaCl, 1.25 mM MgCl2,
2.5 mM 2-mercaptoethanol, pH 7.5, which was diluted
10-fold in water, added to a 1 mm cuvette and kept at 258C,
whereas a 260 to 190 nm CD spectrum was recorded. The per-
centage distribution of a-helix, b-sheet and random coil in the
data was calculated by using the CD data analysis programs
CDSSTR and CONTINLL.
4.4. Thermal shift
5 mM protein sample in SEC buffer was diluted 10-fold in the
same buffer containing imidazole. Next, SYBRO orange fluor-
escent dyewas added to the samples in a final concentration of
1/1000 stock solution and the samples transferred to quartz
cuvettes (Hellma). The samples were now heated from 4 to
808C, in increments of 18C at the rate of 28C min21, while sim-
ultaneously monitoring fluorescence changes with a Cary
Eclipse fluorescence spectrophotometer (Agilent Technol-
ogies). The wavelengths for excitation and emission were 470
and 600 nm, respectively. To obtain the temperature midpoint
for the protein unfolding transition, Tm, the datawere analysed
using the mathematical software Prism. Here, a Boltzmann
model was used to fit the fluorescence data to the following
equation: I ¼ (A þ (B2 A)/(1 þ exp(Tm 2 T )/C), where I is
the fluorescence intensity at temperature T, A and B are pre-
transitional and post-transitional fluorescence intensities,
respectively, and C is the slope factor.
4.5. SEC–MALS
1 mg ml21 protein samples were loaded onto a Superose 6
10/300 column pre-equilibrated in a buffer comprising
rsob.royalsocietypublishing.org
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950 mM sodium phosphate, 100 mM NaCl, 20 mM NaF, 10%
v/v glycerol, 5 mM 2-mercaptoethanol, 3 mM sodium
azide, pH 8.0 at a flow rate of 0.5 ml min21. The column
was mounted on a Varian ProStar high-performance liquid
chromatography controlled by the GALAXIE software package.
The scattered light intensity of the column eluent was
recorded at 18 angles using a DAWN-HELEOS II laser light
scattering detector (Wyatt Technology Corp., Santa Barbara,
CA). The refractive index change was detected using an
OPTILAB-rEX differential refractometer (Wyatt Technology
Corp.). The wavelength of the laser in the DAWN-HELEOS
II, and the light source in the OPTILAB-rEX was 658 nm.
The weight-averaged molecular mass of protein contained
in chromatographic peaks was determined using the
ASTRA software version 5 (Wyatt Technology Corp.). :1600324.6. Electron microscopic and image analysis
Purified separase/securin complex was loaded on to carbon-
coated glow-discharged quantifoil grids and negatively
stained with 2% w/v uranyl acetate. Micrographs were col-
lected on a Tecnai F20 electron microscope operating at
200 kV and recorded using a 4 k  4 k pixel CCD camera
(Tietz) at a nominal 62 000 magnification resulting in a
pixel size of 2.914 A˚ at specimen level. The focal level was
chosen such that the first minimum of the contrast transfer
function was placed at 18 A˚. Low dose settings were used
but with an electric dose of approximately 100 e-/A˚2.
Single molecular views were chosen manually from
micrographs using the graphical program BOXER, which is a
part of the EMAN software [48]. Data stacks were high-
pass filtered to 250 A˚, masked with a circle (radius 0.9),
and normalized to zero mean and standard deviation of 2
in IMAGIC-5 [49]. The data were subsequently low-pass fil-
tered to 15 A˚ with the ‘fq’ command in SPIDER, choosing
the Fermi filter option [50].Initial classification was carried out using an automated
reference-free EMANprocedure (REFINE2D). Here, standard par-
ameters used, for datasets of about 1800–6000 particles, were
300 initial class averages, seven iterations and 1000 final class
averages. The class averages were prepared for further proces-
sing by applying a soft mask using the ‘mask-im’ command in
IMAGIC. A preliminary three-dimensional model was con-
structed in IMAGIC and refined through iterative cycles of
reprojection, projection matching, adjustment of the number
of classes, and visual inspection of the agreement between
class averages and the corresponding reprojections.
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